false
0000101538
UNITED STATES ANTIMONY CORP
0000101538
2025-11-24
2025-11-24
0000101538
UAMY:CommonStockOneMember
2025-11-24
2025-11-24
0000101538
UAMY:CommonStockTwoMember
2025-11-24
2025-11-24
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of report (Date of earliest event reported) November 24, 2025
| UNITED STATES ANTIMONY CORPORATION |
| (Exact name of registrant as specified in its charter) |
| Texas |
|
001-08675 |
|
81-0305822 |
|
(State or other jurisdiction
of incorporation) |
|
(Commission
File No.) |
|
(IRS Employer
Identification Number) |
| 4438
W. Lovers Lane, Unit
100, Dallas,
TX |
|
75209 |
| (Address of principal executive officers) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: (406) 606-4117
Not Applicable
(Former name or former address, if changed since
last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: |
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, $0.01 par value |
|
UAMY |
|
NYSE American |
| Common Stock, $0.01 par value |
|
UAMY |
|
NYSE Texas |
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange
Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ¨
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.02 – Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On November 24,
2025, upon the recommendation of the Governance and Nominating Committee, the Board of Directors (the “Board”) of United States
Antimony Corporation (NYSE: UAMY) (NYSE Texas: UAMY) (“USAC,” “US Antimony,” or the “Company”) appointed
Jon R. Marinelli, to serve as a director of the Company, effective immediately. With Mr. Marinelli’s appointment, the USAC
board size increases to seven members, five of which are Independent. Mr. Marinelli has also been appointed Chairman of a new board
committee formed yesterday, the Finance Committee.
Mr. Marinelli
is a seasoned financial executive and investment professional with more than 25 years of experience in capital markets, M&A, and strategic
advisory roles, and has an early-career background in technology. He is the Founder and Principal of 1042 Capital Partners, where he manages
public and private investments. Previously, he served as Group Head and Managing Director of U.S. Energy at BMO Capital Markets, and before
that held senior roles in Deutsche Bank’s Global Banking–Natural Resources Group, the successor to Bankers Trust. Over his
career, Mr. Marinelli has advised on more than $285 billion in M&A, public and private equity, and debt transactions. He holds
an MBA from Rice University and a BS from Miami University.
Mr. Marinelli will serve until the Company’s
next annual meeting of shareholders and until his successor is duly elected and qualified, or until his earlier death, resignation, or
removal. There are no arrangements or understandings between Mr. Marinelli and any other person pursuant to which he was selected
as a director, and there are no transactions involving Mr. Marinelli that are required to be disclosed under Item 404(a) of
Regulation S-K.
Any compensation payable to Mr. Marinelli
for his service as a director will be consistent with the Company’s previously disclosed standard compensation arrangements for
non-employee directors.
Item 7.01 Regulation FD Disclosure.
On November 25, 2025, US Antimony issued
a press release (“Press Release”) announcing the appointment of Jon R. Marinelli to the Board. A copy of the press release
is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
The information furnished under this Item 7.01,
including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of
1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing
of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, except as expressly set forth by
specific reference in such filing. This Item 7.01 of this Current Report on Form 8-K will not be deemed an admission
as the materiality of any information in this Item 7.01 that is required to be disclosed solely by Regulation FD.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
| Exhibit No. |
|
Description |
| 99.1 |
|
Press Release issued by United States Antimony Corporation dated November 25, 2025 |
| 104 |
|
Cover
Page Interactive Data File (embedded with the inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
UNITED STATES ANTIMONY CORPORATION |
| Dated: |
November 25, 2025 |
|
By: |
/s/ Richard R. Isaak |
| |
|
|
Richard R. Isaak |
| |
|
|
SVP, Chief Financial Officer |
